Predictions for this year from Perry Cohen, Pharm.D., CEO of the TPG Family of Companies and Managed Healthcare Executive editorial advisory board member.
The government’s role in impacting healthcare will be huge in 2025. The Trump administration’s primary objective is focused on undoing the work of previous administrations. They will disrupt healthcare delivery and financing by having people in leadership positions driven by politics and ideology who are not knowledgeable about and committed to the importance of evidence-based science and equitable social policy in advancing and regulating healthcare. HHS, the CDC, the FDA and the National Institutes of Health will lose considerable expertise and become dysfunctional.
Cohen
Access to healthcare will decrease due to undermining or eliminating the Affordable Care Act (ACA). Decreased funding for Medicaid will mean tighter requirements for enrollees. The tightening will be more severe in red states.
Quality of healthcare will decrease due to political and ideology-driven policy at both the federal and state levels due to the changes in Congress and at HHS and the impact of the Supreme Court’s Chevron decision. The out-of-pocket cost of healthcare will skyrocket for patients due to reductions in the ACA, Medicaid and cheap versions of health insurance with limited coverage. Medicare will prioritize Medicare Advantage plans over fee-for-service care, and for-profit healthcare companies will be the beneficiary.
Unrealistic Portrayals of Cardiac Arrest in Contemporary Film | ACC 2025
March 31st 2025Cardiac arrests in contemporary film are largely inaccurate when it comes to survival rate and etiology, according to a poster presented today at the American College of Cardiology conference held March 29 to 31 in Chicago.
Read More
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Winrevair Reduced Risk of Morbidity and Mortality by 76% in PAH | ACC 2025
March 31st 2025In the ZENITH trial, Winrevair was evaluated based on a composite endpoint of all-cause death, lung transplantation or disease-related hospitalization for patients with pulmonary arterial hypertension.
Read More
Clopidogrel Beat Aspirin in Preventing Heart Attacks After PCI | ACC 2025
March 31st 2025Clopidogrel monotherapy may be an alternative to aspirin for prevention of cardiac events in high-risk patients after percutaneous coronary intervention, according to a new study presented at ACC 2025.
Read More